Abbott Laboratories has agreed to pay a $10 million and $27.5 million, depending on pending court rulings, to settle nationwide consumer claims of being overcharged for Abbott's HIV/AIDs drug Norvir.
The proposed settlement attempts to get the Court of Appeals to resolve this and several other legal issues, and to tie the amount of the settlement to the decisions of the Court of Appeals.
